Meditation Risks and Contraindications: When to Proceed with Caution

Meditation carries a reputation for being universally safe — a gentle practice with no side effects, suitable for anyone who can sit still long enough to try it. That reputation is mostly earned, but not entirely. A growing body of clinical research documents real adverse effects in a meaningful minority of practitioners, and certain psychological and physical conditions call for modified approaches or professional supervision before beginning. This page maps those risks, explains the mechanisms behind them, and identifies the decision points where caution is more than just legal boilerplate.

Definition and Scope

"Adverse effects of meditation" refers to unwanted psychological, physiological, or behavioral changes that arise during or following meditation practice and that are plausibly attributable to the practice itself. The scope is broader than most introductory resources suggest.

A landmark 2017 survey published in PLOS ONE by Willoughby Britton and colleagues at Brown University found that 58% of meditators who attended at least one retreat reported at least one unexpected adverse effect, and 6% reported effects severe enough to affect their ability to function in daily life. Those numbers don't indict meditation — they calibrate expectations. The overwhelming majority of people practice without incident. But "most people are fine" is not a contraindication policy, and the wellness space has been slow to develop one.

Contraindications divide into two broad categories:

• Absolute contraindications: Conditions where standard meditation practice poses a high risk of significant harm and should not proceed without clinical supervision. Active psychosis, acute suicidal crisis, and severe dissociative disorders fall here.
• Relative contraindications: Conditions where adaptation, shorter sessions, or professional oversight can make practice safe. A history of trauma, current depressive episodes, early sobriety, and certain cardiovascular conditions fall here.

This distinction matters because treating a relative contraindication as absolute denies potential benefit, while treating an absolute contraindication as relative invites genuine harm.

How It Works

Meditation produces measurable changes in the nervous system — specifically, sustained shifts in autonomic arousal, interoceptive attention (awareness of internal body signals), and cortical activity patterns. For most people, these shifts move in a beneficial direction. For some, the same mechanisms create problems.

Hyperarousal and derealization: Breath-focused and concentration-based practices temporarily suppress default-mode network activity. In individuals with anxiety disorders or trauma histories, this suppression can trigger a rebound hyperarousal response, paradoxically intensifying anxiety rather than reducing it. Separately, deep states of absorption can produce transient feelings of unreality or depersonalization — typically harmless in healthy adults, but destabilizing for people with dissociative conditions.

Trauma surfacing: Meditation for trauma and PTSD warrants its own detailed discussion, but the core mechanism here is direct: sustained inward attention removes the cognitive distraction that functions as a buffer against intrusive memories. Trauma-sensitive protocols, such as those described in David Treleaven's Trauma-Sensitive Mindfulness (W. W. Norton, 2018), address this by allowing practitioners to anchor attention externally when internal focus becomes dysregulating.

Cardiovascular response: Body-scan and relaxation-response practices reduce heart rate and blood pressure. This is generally the goal — but for individuals on antihypertensive medications, the additive effect can produce hypotension. The Herbert Benson-led Relaxation Response research program at Harvard Medical School documented blood pressure reductions of 4–7 mmHg systolic in hypertensive populations, which is therapeutically significant and requires medication monitoring for those already on treatment.

Common Scenarios

The following are the situations where adverse effects appear most consistently in clinical and research literature:

1. Trauma history without trauma-informed guidance: Mindfulness practices that emphasize body awareness can surface somatic trauma responses without the containment strategies that trained therapists provide. The MBSR program has adapted its screening protocols in response to this finding.
2. Acute or recurrent depression: Practices emphasizing present-moment awareness can amplify rumination rather than interrupt it in individuals with active depressive episodes. Behavioral activation or movement-based practices are typically recommended before sitting meditation in these cases.
3. Substance use recovery (early): The altered states produced by deep meditation can resemble intoxication in ways that some individuals in early recovery find destabilizing. Many addiction treatment frameworks delay intensive meditation until 90 days of sobriety are established.
4. Psychosis spectrum conditions: Ego-dissolution experiences, which occur in deep concentration practice, are contraindicated in individuals with schizophrenia or active psychotic symptoms. This is a clinical boundary, not a preference.
5. Pregnancy (advanced): Certain breathwork and body-scan protocols require modification in the third trimester; meditation during pregnancy covers these adjustments in detail.
6. Children with anxiety or ADHD: Meditation for children and teens documents the evidence for shorter, movement-based formats being preferable to extended sitting practice for this group.

Decision Boundaries

The practical question is when to modify, delay, or refer — and to whom.

Modify when a standard practice format produces consistent discomfort but the practitioner has no acute psychiatric history. Shorter sessions (5–10 minutes versus 20–45 minutes), open-eyed practice, walking formats from the walking meditation tradition, or externally anchored attention are effective adaptations.

Delay and consult when a practitioner has a current psychiatric treatment relationship — a therapist, psychiatrist, or prescribing physician — who is unaware that meditation is being added. The meditation and therapy framework specifically addresses how to coordinate these relationships, and the integration is almost always productive rather than conflicted.

Refer when someone presents with active symptoms in the absolute contraindication categories. Referral is not refusal — it is sequencing. Stabilization first, practice adaptation second.

A working reference point from the broader meditation science and research literature: the risks documented to date are concentrated in intensive retreat settings and extended daily practice (defined as 30 or more minutes per day sustained over multiple weeks). Beginner-level practice, as covered on the main site, operates at substantially lower intensity, and the documented risk profile is correspondingly lower.